Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

No Difference in Survival or Long-Term Disease Outcomes in Palifermin-Treated Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplantation.

Ricardo Spielberger, MD, Mary Territo, MD, Simon Durrant, MD, Stephen Nimer, MD, John McCarty, MD, David Hurd, MD, Dietmar Berger, MD, Jeff Aycock, Mon-Gy Chen, Patrick Stiff, MD

Blood (2007) 110 (11): 1664.

https://doi.org/10.1182/blood.V110.11.1664.1664

Published: 2007

Journal Articles

The Transfusion Iron Overload Score Is a Potential Predictor of Survival in Stem Cell Transplant Patients.

Jonathan A. Storey, MD, Rebecca Connor, M.D., Zachary T. Lewis, M.D., James Lovato, David Hurd, M.D., Frank M. Torti, M.D., Istvan Molnar, M.D.

Blood (2007) 110 (11): 1108.

https://doi.org/10.1182/blood.V110.11.1108.1108

Published: 2007

Journal Articles

Markers of Iron Overload Are Poor Prognostic Factors in Stem Cell Transplantation.

Rebecca Connor, MD, Istvan Molnar, MD, James Lovato, Manisha Grover, MD, David Hurd, MD, Gregory Pomper, MD, Suzy V. Torti, PhD, Frank M. Torti, MD

Blood (2005) 106 (11): 5228.

https://doi.org/10.1182/blood.V106.11.5228.5228

Published: 2005

Journal Articles

Addition of GM-CSF to Imatinib Results in Major Cytogenetic Response in Patient with Chronic Myeloid Leukemia (CML).

Rebecca Connor, MD, David Hurd, MD, Istvan Molnar, MD

Blood (2005) 106 (11): 4884.

https://doi.org/10.1182/blood.V106.11.4884.4884

Published: 2005

Journal Articles

Intense Immunochemotherapy (IC) and Autologous Stem Cell Transplant (ASCT) for Untreated Patients (pts) with Mantle Cell Lymphoma (MCL): CALGB 59909. A Preliminary Report.

Lloyd Damon, Donna Niedzwiecki, Jeff Johnson, Bruce Cheson, David Hurd, Nancy Barlett, Michael Kelly, Charles Linker, George Canellos

Blood (2004) 104 (11): 895.

https://doi.org/10.1182/blood.V104.11.895.895

Published: 2004

Journal Articles

Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide

Peter Westervelt, Randy A. Brown, Douglas R. Adkins, Hanna Khoury, Peter Curtin, David Hurd, Selina M. Luger, Margaret K. Ma, Timothy J. Ley, John F. DiPersio

Blood (2001) 98 (2): 266–271.

https://doi.org/10.1182/blood.V98.2.266

Published: 2001

Journal Articles

Molecular Characterization of the t(8; 13)(p11;q12) Translocation Associated With an Atypical Myeloproliferative Disorder: Evidence for Three Discrete Loci Involved in Myeloid Leukemias on 8p11

Ivan H. Still, Olga Chernova, David Hurd, Richard M. Stone, John K. Cowell

Blood (1997) 90 (8): 3136–3141.

https://doi.org/10.1182/blood.V90.8.3136

Published: 1997

NARROW

No Difference in Survival or Long-Term Disease Outcomes in Palifermin-Treated Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplantation.

The Transfusion Iron Overload Score Is a Potential Predictor of Survival in Stem Cell Transplant Patients.

Markers of Iron Overload Are Poor Prognostic Factors in Stem Cell Transplantation.

Addition of GM-CSF to Imatinib Results in Major Cytogenetic Response in Patient with Chronic Myeloid Leukemia (CML).

Intense Immunochemotherapy (IC) and Autologous Stem Cell Transplant (ASCT) for Untreated Patients (pts) with Mantle Cell Lymphoma (MCL): CALGB 59909. A Preliminary Report.

Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide

Molecular Characterization of the t(8; 13)(p11;q12) Translocation Associated With an Atypical Myeloproliferative Disorder: Evidence for Three Discrete Loci Involved in Myeloid Leukemias on 8p11

Email alerts

ASH Publications

American Society of Hematology

No Difference in Survival or Long-Term Disease Outcomes in Palifermin-Treated Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplantation.

The Transfusion Iron Overload Score Is a Potential Predictor of Survival in Stem Cell Transplant Patients.

Markers of Iron Overload Are Poor Prognostic Factors in Stem Cell Transplantation.

Addition of GM-CSF to Imatinib Results in Major Cytogenetic Response in Patient with Chronic Myeloid Leukemia (CML).

Intense Immunochemotherapy (IC) and Autologous Stem Cell Transplant (ASCT) for Untreated Patients (pts) with Mantle Cell Lymphoma (MCL): CALGB 59909. A Preliminary Report.

Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide

Molecular Characterization of the t(8; 13)(p11;q12) Translocation Associated With an Atypical Myeloproliferative Disorder: Evidence for Three Discrete Loci Involved in Myeloid Leukemias on 8p11

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only